Klick Health Builds Out Global Leadership Team and Offices
10.11.2022 12:03:00 EET | Business Wire | Press release
Building on its recent news about taking the company global, Klick Health today made several senior, global leadership team announcements as it builds out regional hubs in Asia-Pacific (APAC); Europe, the Middle East, and Africa (EMEA); and Latin America (LATAM).
Klick Health CEO Lori Grant welcomed agency veterans Jennifer Lambert and Roberta Raduan as its first global Managing Directors, and accomplished operations professionals Michael Becker, Shaun Chalk, and Catherine MacInnis to help lead its global operations and growth. The new senior executives will build on Klick’s strong people-first business model and supporting foundations, and work alongside seasoned Klick leaders Glen Webster, who has been named Executive Vice President, Global Operations; and Jennifer White, Global Head of Growth.
“We couldn’t be happier to welcome Jen Lambert, Roberta, Shaun, Mike, and Catherine to Klick–they are all proven leaders in their fields and have the global expertise required for a successful global rollout,” said Grant. “We’re also thrilled to announce Glen’s and Jen White’s new global roles–they have both contributed immeasurably to our industry-leading success and will be instrumental in helping us scale the Klick magic overseas.”
Jennifer Lambert – Managing Director, EMEA
A proven leader in growing agencies, managing client relations, and launching campaigns across the globe, Lambert joins Klick as Managing Director of EMEA. She spent the last decade at WPP, most recently as Chief Health Officer at Wunderman Thompson Health International, with many years serving as WPP lead for Team Pfizer, overseeing all the operations and talent across EMEA for the large network agency. Prior, she spent 15 years at Sudler & Hennessey, growing the agency’s presence across EMEA and Asia-Pacific. Lambert began her career at Ogilvy in New York after earning a biomedical degree at Rutgers University. She has worked across the spectrum of all therapeutic areas and has extensive expertise internationally within CRM, DTC, omnichannel, and brand defense/LTV strategy planning. Outside of work, Jennifer donates her time to helping create change in health, including working on pro-bono platforms with the United Nations, NGOs, and academia to help drive support for victims of sexual abuse and violence.
“I joined Klick because there is something really different here,” Lambert said. “I love the entrepreneurial spirit and incredible energy you get from a large, independent powerhouse like Klick, and I’m thrilled to be helping bring Klick’s end-to-end services to life sciences clients in Europe, the Middle East, and Africa and creating real healthcare change across the globe.”
Roberta “Beta” Raduan – Managing Director, LATAM
Based out of São Paulo, Brazil, Raduan brings to Klick her proven entrepreneurial track record building successful agencies and her long-standing relationships with both clients and top talent in Latin America. A digital native and seasoned marketing communications professional with a strategic understanding of brands and business opportunities in the digital, data, and communication arenas, Raduan has spent the last 25+ years helping global and local B2B, CPG, fintech, FMCG, and telco brands achieve transformational growth. Most recently, she was Managing Director of Havas CX Brasil, previously serving as Digital Managing Director of Havas Brasil. Raduan was also a co-founding Partner and Managing Director of several São Paulo agencies, including Versão Beta, Sinc, and Euro RSCG 4D (Havas).
“I am thrilled about launching Klick in Latin America and bringing its award-winning, people-first approach here,” said Raduan. “I was drawn to Klick’s unique culture and its obsession for identifying and hiring top talent. Klick’s commitment to keep evolving to exceed clients’ needs and make the world a better, healthier place really resonates with my heart and soul.”
Michael Becker – Chief Financial Officer, Klick Group
Becker joins as Klick Group CFO with invaluable global finance leadership in the life sciences industry. Formerly a Senior Vice President at Pharmaceutical Product Development (PPD), he led a team of more than 450 global finance professionals. During his tenure at the industry-leading contract research organisation, Becker played a primary role in a number of its key strategic initiatives, Becker previously served as PPD’s Executive Director of Operations and Executive Director of Internal Audit. Prior, he spent 12 years in public accounting at Deloitte & Touche, mainly in external audit roles.
“I’m very excited to join Klick Group as CFO and serve as a strategic business partner to its forward-thinking, world-class leaders,” Becker said. “What the Klick team has done over the past 25 years is truly remarkable and a testament to the culture of excellence here. I look forward to helping build on Klick’s existing strong foundations as we scale the business further to support our people, our clients, and the patients they serve.”
Shaun Chalk – Executive Vice President, Global Client Operations
Chalk joins Klick in the newly minted role of EVP of Global Client Operations, focused on enhancing strategic value to clients and creating compelling commercial narratives across the organisation, as it scales internationally. He brings 25+ years of marketing & communication, commercial, finance and operational experience to the role–the last eight years at WPP, most recently as Chief Commercial Officer at WPP Health & Wellness. Previously, he was Global CFO for McCann Worldgroup’s Commonwealth and a Director of Global Operations & Technology at Citigroup. He spent his early career at Wunderman, Y&R, and Ogilvy, where he worked in senior finance and commercial positions in both U.S. and worldwide groups. Chalk has an MBA and Accounting and Economics degrees.
“This is a very exciting time to be joining Klick, with the opportunity to contribute to its continued growth and success as it continues to expand globally,” said Chalk. “I look forward to embracing the Klickster culture, partnering with our teams to deliver on our clients’ goals and objectives, and ultimately helping to improve health outcomes for more patients around the world.”
Catherine MacInnis – General Counsel
As General Counsel, MacInnis is responsible for Klick’s risk and legal portfolio worldwide, with a focus on growth, compliance, insurance, and corporate governance. She leads all legal aspects of the company’s global expansion, including strategic decision-making, as well as all corporate/commercial, employment, immigration, and privacy matters related to the expansion. She has contributed to the annual World Bank report on business regulation (Doing Business) and presents frequently on risk management for professional services providers. Prior to joining Klick, MacInnis served as Associate General Counsel at publicly traded, design-driven technology firm IBI Group from its global headquarters in Toronto. There, she was key in managing the growth of its award-winning legal team as the company quickly scaled to 3,300 people with offices around the world. Earlier in her career, she spent four years in Commercial Litigation at Blaney McMurtry LLP, and three years as a securities & commercial litigator at Groia & Company.
MacInnis said, “I joined Klick because I have the phenomenal opportunity to work with Klick’s industry thought leaders on very cool projects, including global expansion, and I could not be more excited to help make the vision of our incredible team a reality.”
Glen Webster, Executive Vice President, Global Operations
For almost two decades, Webster has played a pivotal role in laying the strong foundation for Klick’s award-winning workplace culture and industry-leading business performance. He has consistently helped inoculate Klick against the status quo and think differently–establishing and piloting many internal operational capabilities over the years, including in-house Culture & Engagement, Recruiting, Marketing, Contracts, Tax, Strategic Alliances, and Performance Management, eventually evolving them into departments run by others. Webster began his career 30 years ago in management consulting, working at Deloitte Consulting, CGI, and Price Waterhouse, and serving a diverse set of clients, including Astra Pharma, Bank of Montreal, and Sony. He has strong entrepreneurial roots, started Canada's first online retail drugstore during the dot-com boom (and winding it up during the bust), and selling enterprise software to clients, like Goldman Sachs. He has also served as a part-time professor, teaching at post-secondary institutions, such as the MBA program at the Schulich School of Business at York University, before finally joining Klick in 2006.
“I’ve spent more than half of my career focused on Klick’s growth and am incredibly energised about helping lead the charge in this exciting new chapter of our company’s history,” said Webster. “Going global means access to brilliant new talent markets and making more client wishes come true as we share the Klick difference with the whole world!”
Jennifer White, Global Head of Growth
White has spent over 20 years working across multiple healthcare industry segments in the U.S. and abroad, most recently as an Executive Vice President of Growth at Klick. With her deep understanding of every facet of the commercialisation lifecycle of healthcare clients, White will continue to drive the operationalisation and scaling of Klick’s growth efforts in North America in her new role as Global Head of Growth. She will also help commercialise Klick’s new global marketing model for the life sciences industry, which is designed to drive efficiency and scalability of marketing initiatives around the world, and leverages the full suite of assets within the Klick ecosystem to provide an agile and insights-driven global marketing approach, while synergistically incorporating critical local and regional nuances. Prior to Klick, White served as the founding Chief Commercial Officer for Circulation, where she led the company’s commercial efforts from their pre-revenue phase through the close of their $10.5 million Series A round. Earlier in her career, she held executive leadership roles at both WebMD and Aptus Health.
“I am incredibly grateful to have the opportunity to heighten my work in healthcare and growth to help drive commercial success for Klick’s new global model,” White said. “I’m also excited about the plans our team has to disrupt and transform antiquated global marketing approaches with a forward-thinking, agile model that honors the unique needs of local markets, while creating global campaigns in an efficient and scalable manner.”
According to Klick Co-President Ari Schaefer, “We’re delighted with how our global expansion is developing and by the response we’ve been getting around the world. This is just the beginning–we will have more exciting news to share in the near future.”
About Klick Health
Klick Health is the world’s largest independent commercialisation partner for life sciences. For over 25 years, Klick has been laser-focused on developing, launching, and supporting life sciences brands to maximise their full market potential as a core commercialisation partner. Klick recently ranked #1 on Medical Marketing + Media (MM+M) magazine’s Agency 100 list for the fifth straight year and was named an MM+M Large Agency of the Year for both 2020 and 2021, marking 10 Agency of the Year industry awards in 11 years. Follow Klick Health on LinkedIn and for more information on joining Klick, go to careers.klick.com.
About Klick Group
The Klick Group of companies–Klick Health (including Klick Katalyst), Klick Media Group, Klick Applied Sciences (including Klick Labs), Klick Consulting, Klick Ventures, and Sensei Labs–is an ecosystem of brilliant talent collectively working to maximise their people’s and clients’ full potential. Established in 1997, Klick has teams across North America, with offices in New York, Philadelphia, and Toronto, and is opening global offices in Basel, Buenos Aires, London, Munich, Paris, Singapore, São Paulo, and Tokyo. Klick has consistently been named a Best Managed Company and Great Place to Work. In 2021, the company was recognised with 15 Best Workplace awards, including Best Workplaces for Women, Best Workplaces for Inclusion, Best Workplaces for Giving Back, Fast Company’s Best Workplaces for Innovators, and FORTUNE’s Best Workplaces for Millennials.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221027006033/en/
Contact information
Sheryl Steinberg, Senior Vice President, Communications
416-214-4977 ext. 2412 pr@klick.com
Marisa McWilliams, Senior Manager, Communications
862-335-8165 pr@klick.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim2.9.2026 15:00:00 EEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 15:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
Croma-Pharma Introduces Electronic Instructions for Use Across the saypha ® Portfolio2.9.2026 14:37:00 EEST | Press release
Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructions for Use across the saypha® portfolio reflects our focus on practical digital solutions that support healthcare professionals and align with evolving regulatory requi
Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building2.9.2026 14:13:00 EEST | Press release
Across Oman, Orascom Development and its Sultanate platform, Muriya, are moving forward. While parts of the region grow cautious, Muriya has paused nothing, building and delivering across all three destinations: Hawana Salalah, Jebel Sifah and As Sodah Island. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260902781576/en/ Moving Forward in Oman: Orascom, Samih Sawiris and Muriya Keep Building (Photo: AETOSWire) The same steadiness runs through everything Samih Sawiris and Orascom have built, from El Gouna to Andermatt to Mamula Island: identifying extraordinary places and developing them for the long term. “Oman has everything we look for as a long-term developer: stability, natural beauty, and a clear direction for its future. Our continued investment across all three destinations reflects that conviction — we build for decades, and Oman is a country we intend to grow with in all circumstances.” — Naguib S. Sawiris, Chairm
Aukera Closes €460 Million Structured Credit Facility Led by EIG to Support European Energy Infrastructure Portfolio2.9.2026 14:00:00 EEST | Press release
Aukera, the pan-European battery storage and renewable energy platform backed by AtlasInvest, Reggeborgh and SFPIM (Belgium's sovereign wealth fund), announced the closing of its €460 million structured credit facility, for which EIG, a leading institutional investor in the global energy and infrastructure sectors, served as the lead investor. With the financing in place, Aukera moves into its next phase of growth, combining capital, expertise and delivery capability to build a significant European energy infrastructure platform that develops, finances, constructs and operates assets at scale. The original facility included an initial €200 million commitment and an accordion feature of up to €250 million. The amended facility converts that accordion into a firmly committed €260 million Series 2 tranche, increasing total committed capital to €460 million. The additional capital will support the continued advancement of Aukera's portfolio of renewable energy generation, battery storage a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
